Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, April 18, 2024 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Action

RALEIGH, N.C. - A shareholder class action claims Cempra Inc. and its executives failed to disclose that an antibiotic it developed to treat bacterial pneumonia and urethritis poses significant health risks to some individuals. The class claims when this information became public, the value of their shares dropped from $18.65 to $7.30 in a single day.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...